-
Raw materials are in short supply, and the United States cannot guarantee its own "medicine jar"
-
[editor's note] API low profits, environmental pressure is an important reason. In addition, some cheap drugs in China itself are out of stock. The Ministry of Industry and Information Technology has announced two batches of designated production bases for shortage drugs, and plans to realize the collection of 100 small varieties of drugs by 2020.
